Vir Biotechnology, Inc. (NASDAQ:VIR – Get Free Report) has received an average recommendation of “Moderate Buy” from the six ratings firms that are covering the stock, Marketbeat reports. One ...
As I have posted, I am a top 8 predictor on Metaculus out of 34617 people according to Metaculus for baseline accuracy. I was ...
Prime Minister Narendra Modi met Indian-American entrepreneur Vivek Ramaswamy in Washington to discuss India-US relations, ...
LIXTE Biotechnology (LIXT) announced the closing of its previously announced registered direct offering priced at-the-market ...
The Modesto Bee on MSN2h
From fashion to finance, Modesto high schools offer over a dozen career and technical pathsAll high schools, including Elliot Alternative, offer the design, visual and media arts pathway. Davis, Downey, Gregori and ...
Press Trust of India on MSN16h
PM Modi meets Indian-origin entrepreneur Vivek Ramaswamy, discusses innovation and biotechnologyPrime Minister Narendra Modi on Thursday met Indian-American billionaire entrepreneur Vivek Ramaswamy here and the two ...
Speaking this week at BIO CEO, the heads of Septerna, Upstream Bio and Actuate Therapeutics shared lessons from going public ...
ThePrint on MSN14h
How Chinese biotech firm BGI grew to rival US giant Illumina & enter US-China tariff warChina has put Illumina on its ‘unreliable entity list’ after the US imposed sanctions on Beijing Genomics Institute, also a ...
Equities research analysts at Leerink Partnrs dropped their Q4 2024 earnings per share estimates for United Therapeutics in a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback